Back to Search
DR. PAUL BRIAN CHAPLIN M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1487747168IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
0037481(FL)ME37481(FL)
Education
NEW YORK MEDICAL COLLEGE
Class of 1979
Research & Publications (20)
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.
PMID 19539582·Vaccine·2009
7-preclinical
Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.
PMID 19632316·Vaccine·2009
4-observational
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
PMID 18398511·J Clin Invest·2008
7-preclinical
Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
PMID 18024893·J Gen Virol·2007
7-preclinical
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge.
PMID 18036708·Vaccine·2007
2-rct
Project Universal Preschool Vision Screening: a demonstration project.
PMID 16452332·Pediatrics·2006
8-other
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
PMID 16337719·Vaccine·2006
3-trial
Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
PMID 15919938·J Virol·2005
7-preclinical
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
PMID 15627214·Cancer Immunol Immunother·2005
3-trial
Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.
PMID 15865223·Antivir Ther·2005
3-trial
Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice.
PMID 15128820·J Immunol·2004
7-preclinical
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
PMID 15328176·Clin Cancer Res·2004
3-trial
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
PMID 14503969·Hum Gene Ther·2003
3-trial
Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias.
PMID 12594287·J Immunol·2003
7-preclinical
Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides.
PMID 12874211·J Immunol·2003
7-preclinical
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
PMID 12917462·J Gen Virol·2003
7-preclinical
Efficacy of DNA vaccination by different routes of immunisation in sheep.
PMID 12406655·Vet Immunol Immunopathol·2002
3-trial
Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis.
PMID 11895958·Infect Immun·2002
7-preclinical
Fasciola hepatica cathepsin L suppresses sheep lymphocyte proliferation in vitro and modulates surface CD4 expression on human and ovine T cells.
PMID 11874560·Parasite Immunol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via SILVERMAN, WENDER, KOONIN, EPSTEIN, GARCIA & ROZENCWAIG, P.A. · 2 locations total
- Address
- 21000 NE 28TH AVE STE 104
AVENTURA, FL 33180 - Phone
- (305) 937-1999
Quick Facts
- NPI
- 1487747168
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile